Detection and clinical implications of early systemic tumor cell dissemination in breast cancer
Blood-borne distant metastasis is the leading cause of cancer-related death in breast
cancer. The onset of this fundamental process can now be assessed in cancer patients …
cancer. The onset of this fundamental process can now be assessed in cancer patients …
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
K Pantel, V Müller, M Auer, N Nusser, N Harbeck… - 2003 - mediatum.ub.tum.de
Blood-borne distant metastasis is the leading cause of cancer-related death in breast
cancer. The onset of this fundamental process can now be assessed in cancer patients …
cancer. The onset of this fundamental process can now be assessed in cancer patients …
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer
K Pantel, V Müller, M Auer, N Nusser… - … : an official journal …, 2003 - pubmed.ncbi.nlm.nih.gov
Blood-borne distant metastasis is the leading cause of cancer-related death in breast
cancer. The onset of this fundamental process can now be assessed in cancer patients …
cancer. The onset of this fundamental process can now be assessed in cancer patients …
[引用][C] Detection and clinical implications of early systemic tumor cell dissemination in breast cancer
K PANTEL, V MÜLLER, M AUER… - Clinical cancer …, 2003 - pascal-francis.inist.fr
Detection and clinical implications of early systemic tumor cell dissemination in breast
cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
K Pantel, V Müller, M Auer, N Nusser… - … Cancer Research: an …, 2003 - europepmc.org
Blood-borne distant metastasis is the leading cause of cancer-related death in breast
cancer. The onset of this fundamental process can now be assessed in cancer patients …
cancer. The onset of this fundamental process can now be assessed in cancer patients …